Phio Pharmaceuticals Corp.
PHIONASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $9.88M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.81$4.19
- Volume (live)
- -
- Avg. volume (3M)
- 95.90K
Phio Pharmaceuticals (PHIO) Stock Price & Financial Analysis
Phio Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.85 - $0.90 |
|---|---|
| 52-Week High | $4.19 |
| 52-Week Low | $0.81 |
| Open | $0.88 |
| Volume (last close) | 43.07K |
| Average Volume (3M) | 95.90K |
| 50-Day MA | $1.04 |
|---|---|
| 200-Day MA | $1.10 |
| 1-Year Change | −59.23% |
| Market Cap | 9.88M |
|---|---|
| Shares Outstanding | 11.62M |
| Price to Book (P/B) | 0.78 |
| EV/EBITDA | 0.22 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Phio Pharmaceuticals at a Glance
As of the Oct 26, 2026 close, Phio Pharmaceuticals (PHIO) has a market capitalization of $9.88M.
As of its latest reported balance sheet, it holds $13.00M in cash and securities against $0.00 of debt, a net cash position of $13.00M.
Phio Pharmaceuticals does not currently pay a dividend.
The share price is down 59.2% over the past year. At $0.85 (the Oct 26, 2026 close) it sits near the bottom of its 52-week range of $0.81 to $4.19, below its 200-day moving average of $1.10.
Frequently Asked Questions About Phio Pharmaceuticals
What is the current stock price for PHIO?
As of the Oct 26, 2026 close, PHIO stock trades at $0.85. The 52-week range is $0.81–$4.19, with a day range of $0.85–$0.90.
What is the P/E ratio for PHIO?
The P/E ratio (Price-to-Earnings) for PHIO is shown in the Key Statistics section. This valuation metric helps compare Phio Pharmaceuticals Corp. to industry peers.
Does PHIO pay dividends?
Phio Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for PHIO?
Analyst ratings and recommendations for PHIO are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of PHIO?
As of the Oct 26, 2026 close, Phio Pharmaceuticals's market capitalization is $9.9M, classifying it as a micro-cap company. Phio Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.